Qualigen Therapeutics Inc (QLGN)

01:54 AM

Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World

01:54 AM

Nov 14, 2024

Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Qualigen Therapeutics appoints new board member - Investing.com

Nov 14, 2024

Nov 13, 2024

QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada

Nov 13, 2024

Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India

Nov 11, 2024

Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK

Nov 11, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Nov 06, 2024

Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com

Nov 06, 2024

Nov 05, 2024

QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com

Nov 05, 2024

Nov 03, 2024

Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World

Nov 03, 2024

Nov 01, 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire

Nov 01, 2024

Nov 01, 2024

Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split - TipRanks

Nov 01, 2024

Oct 30, 2024

Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register

Oct 30, 2024

Oct 30, 2024

Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India

Oct 29, 2024

Oct 26, 2024

Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com

Oct 26, 2024

Oct 25, 2024

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR

Oct 25, 2024

Oct 25, 2024

QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India

Oct 25, 2024

Oct 23, 2024

Qualigen Therapeutics faces Nasdaq delisting notice By Investing.com - Investing.com Canada

Oct 23, 2024

Oct 22, 2024

Qualigen Therapeutics faces Nasdaq delisting notice - Investing.com India

Oct 22, 2024

Oct 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Shares Up 4.4% – Here’s Why - Defense World

Oct 19, 2024

Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair By Investing.com - Investing.com South Africa

Oct 09, 2024

Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair - Investing.com India

Oct 09, 2024

Sep 27, 2024

Qualigen Therapeutics sees major executive reshuffle By Investing.com - Investing.com Canada

Sep 27, 2024

Sep 27, 2024

Qualigen Therapeutics, Inc. Announces management changes. - The Manila Times

Sep 27, 2024

Sep 26, 2024

Qualigen Therapeutics appoints new leadership amid strategic shift By Investing.com - Investing.com South Africa

Sep 26, 2024

Sep 26, 2024

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Sees Large Decline in Short Interest - Defense World

Sep 26, 2024

Sep 26, 2024

Qualigen Therapeutics sees major executive reshuffle - Investing.com

Sep 26, 2024

Sep 26, 2024

Qualigen Therapeutics appoints new leadership amid strategic shift - Investing.com

Sep 26, 2024

Sep 26, 2024

Qualigen Therapeutics Announces Executive Shakeup and Board Revamp - TipRanks

Sep 26, 2024

Sep 23, 2024

Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex

Sep 23, 2024

Sep 20, 2024

Qualigen Therapeutics granted Nasdaq listing extension - Investing.com

Sep 20, 2024

Sep 20, 2024

Qualigen Therapeutics granted Nasdaq listing extension By Investing.com - Investing.com Australia

Sep 20, 2024

Sep 20, 2024

Qualigen Therapeutics receives extension from Nasdaq hearings panel - TipRanks

Sep 20, 2024

Sep 20, 2024

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewswire

Sep 20, 2024

Sep 19, 2024

Garner Asset Management Corp Purchases 1,151 Shares of QUALCOMM Incorporated (NASDAQ:QCOM) - Defense World

Sep 19, 2024

Sep 19, 2024

Quorn faces £63.4m loss as UK and US meat-free market sales decline - Express

Sep 19, 2024

Sep 19, 2024

QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity - Zacks Investment Research

Sep 19, 2024

Sep 19, 2024

Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 19, 2024

Sep 19, 2024

Quorn: Meat-free food brand loses more than £60m as supermarket sales slashed - City A.M.

Sep 19, 2024